WINTON GROUP Ltd Invests $6.21 Million in Revvity Inc. $RVTY

WINTON GROUP Ltd acquired a new stake in shares of Revvity Inc. (NYSE:RVTY) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 64,193 shares of the company’s stock, valued at approximately $6,211,000. WINTON GROUP Ltd owned approximately 0.06% of Revvity as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in RVTY. AQR Capital Management LLC grew its position in Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after purchasing an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after purchasing an additional 744 shares in the last quarter. Millennium Management LLC grew its position in Revvity by 102.0% during the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after purchasing an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after purchasing an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth grew its position in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after purchasing an additional 811 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Price Performance

NYSE RVTY opened at $98.46 on Friday. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $10.98 billion, a PE ratio of 47.11, a price-to-earnings-growth ratio of 2.15 and a beta of 1.11. The company has a 50 day moving average price of $93.40 and a two-hundred day moving average price of $97.49. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the previous year, the company earned $1.01 earnings per share. The company’s revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts predict that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is presently 13.40%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on RVTY shares. Stifel Nicolaus lowered their price objective on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. TD Cowen boosted their price objective on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings downgraded shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. The Goldman Sachs Group reduced their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research note on Tuesday, April 14th. Finally, Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Revvity currently has an average rating of “Hold” and a consensus target price of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.